Bilix Co., Ltd.
🇰🇷South Korea
Clinical Trials
1
Active:0
Completed:1
Trial Phases
1 Phases
Phase 1:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 1
1 (100.0%)A Study to Evaluate the Safety and Pharmacokinetics of BX-001N in Healthy Participants
Phase 1
Completed
- Conditions
- Ischemia-reperfusion Injury
- Interventions
- Drug: BX-001N Part 1Drug: BX-001N Part 2Drug: Placebo
- First Posted Date
- 2023-10-24
- Last Posted Date
- 2025-04-17
- Lead Sponsor
- Bilix Co.,Ltd.
- Target Recruit Count
- 51
- Registration Number
- NCT06097702
- Locations
- 🇦🇺
CMAX Clinical Research, Adelaide, South Australia, Australia
News
No news found